Showing results (61-70 of 76) with videos related to
Sort By:
Pageof 8
Urology|October 13, 2001
Plasma levels of IGF-1, IGF-2, and IGFBP-3 in white and African-American men at increased risk of prostate cancerD L Winter, A L Hanlon, S L Raysor, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynxD A Fein, W R Lee, A L Hanlon, et al.Urology|July 22, 1999
Racial differences in insulin-like growth factor binding protein-3 in men at increased risk of prostate cancerJ V Tricoli, D L Winter, A L Hanlon, et al.International Journal of Radiation Oncology, Biology, Physics|July 15, 1996
Conformal technique dose escalation for prostate cancer: biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen > or = 10 NG/MLG E Hanks, W R Lee, A L Hanlon, et al.Urology|April 18, 2001
Increased hypoxia correlates with increased expression of the angiogenesis marker vascular endothelial growth factor in human prostate cancerD Cvetkovic, B Movsas, A P Dicker, et al.American Journal of Clinical Oncology|October 5, 2001
Hypoxia in human prostate carcinoma: an Eppendorf PO2 studyB Movsas, J D Chapman, A L Hanlon, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2003
Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089T E Le Voyer, E R Sigurdson, A L Hanlon, et al.Urology|January 14, 1999
Hypoxic regions exist in human prostate carcinomaB Movsas, J D Chapman, E M Horwitz, et al.Cancer|November 7, 2000
Increasing levels of hypoxia in prostate carcinoma correlate significantly with increasing clinical stage and patient age: an Eppendorf pO(2) studyB Movsas, J D Chapman, R E Greenberg, et al.International Journal of Radiation Oncology, Biology, Physics|July 1, 1996
The impact of tamoxifen on breast recurrence, cosmesis, complications, and survival in estrogen receptor-positive early-stage breast cancerB Fowble, D A Fein, A L Hanlon, et al.Pageof 8